Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DAPSONE 100 MG TABLET

dapsone
$1.0787per EA

Strength

100 mg/1

Manufacturer

Rising Pharma Holdings Inc.

NDC

64980056603

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DAPSONE

Approval Type

Generic (ANDA)

FDA Application

ANDA207165

On Market Since

12/11/2022

Pharmacological Classes

Sulfone
Sulfones

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

+6.3%

1Y

-1.9%

3Y

N/A

5Y

N/A

All

+1.5%

Generic Alternatives

1 alternative • Same active ingredient

DAPSONE 100 MG TABLET
Generic
64980056601•Rising Pharma Holdings Inc.
$1.0787

Related Drugs

Same classification

DAPSONE 25 MG TABLET
Generic
13925050401•Seton Pharmaceuticals
$0.5165
per EA
DAPSONE 25 MG TABLET
Generic
69367037801•Westminster Pharmaceuticals LLC
$0.5191
per EA
DAPSONE 25 MG TABLET
Generic
69367037830•Westminster Pharmaceuticals LLC
$0.5191
per EA
DAPSONE 25 MG TABLET
Generic
69367040901•Westminster Pharmaceuticals LLC
$0.5191
per EA
DAPSONE 25 MG TABLET
Generic
69367040930•Westminster Pharmaceuticals LLC
$0.5191
per EA
DAPSONE 25 MG TABLET
Generic
70954013510•ANI Pharmaceuticals, Inc.
$0.5191
per EA
DAPSONE 25 MG TABLET
Generic
70954013520•ANI Pharmaceuticals, Inc.
$0.5191
per EA
DAPSONE 5% GEL
Generic
16714095601•NorthStar Rx LLC
$0.7350
per GM
DAPSONE 5% GEL
Generic
21922001807•Encube Ethicals, Inc.
$0.7350
per GM
DAPSONE 5% GEL
Generic
51672138703•Sun Pharmaceutical Industries Inc.
$0.7350
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy